News Releases
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Feb 18, 2015
-
Feb 13, 2015Patients Can Now Be Removed from Respiratory Isolation Following One or Two Negative Xpert MTB/RIF Results
-
Jan 29, 2015Fourth Quarter Commercial Clinical Up 26% Driven by 29% Growth in Xpert® Reagents
-
Jan 5, 2015
-
Dec 29, 2014Quantitative Test for Rapid Measurement of the HIV-1 Viral Load in Plasma Delivers Individual Results in About 90 Minutes
-
Dec 1, 2014Accurate Norovirus Detection in as Little as One Hour
-
Nov 24, 2014Redundant targets extend coverage for detection of seasonal and emerging novel viruses
-
Nov 20, 2014
-
Nov 13, 2014With Funding from the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, Cepheid Expects to Deliver Prototype in as Little as Eight Weeks
-
Oct 16, 2014Commercial Clinical Grows 23% Driven by 25% Growth in Xpert Tests
-
Oct 1, 2014Acquires Customer Relationships from Former Distribution Partner
-
Sep 4, 2014
-
Sep 3, 2014First molecular test indicated for samples from both males and females
-
Sep 2, 2014Redundant targets extend coverage to provide detection of seasonal and emerging novel viruses
-
Jul 31, 2014
-
Jul 30, 2014No Customer or Revenue Impact Expected
-
Jul 29, 2014Program to Enable Broader Access to Groundbreaking Tuberculosis Diagnostic
-
Jul 17, 2014Record HBDC Placements and Strength in North America Reagents Drive 27% Clinical Growth
-
Jun 19, 2014Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK
-
Jun 16, 2014On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1
-
May 22, 2014
-
Apr 29, 2014
-
Apr 17, 2014Strong Commercial and HBDC Drive Clinical Growth of 26%
-
Apr 10, 2014Accurate Norovirus Detection in as Short as One Hour
-
Apr 2, 2014Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells
-
Mar 21, 2014Partnering to Increase Awareness About Tuberculosis, a Curable and Preventable Disease that Infects One-third of the World's Population
-
Mar 20, 2014Custom Bike Designed by Paul Teutul Jr. to Lead the March Down Broadway to Highlight the Fight Against Tuberculosis in Honor of World TB Day
-
Jan 30, 2014Record Commercial GeneXpert® System Placements and Strong Commercial Reagent Growth Highlight Building Momentum as Xpert® Test Menu Expands
-
Dec 18, 2013
-
Oct 17, 2013First $100 Million Revenue Quarter Driven by Record Commercial Clinical and HBDC Sales
-
Aug 28, 2013Revolutionary Tuberculosis Test Brings Accurate, Faster Results to Broader U.S. Market
-
Aug 15, 2013Text RIDE to 50555 to Join our Mobile Community and Enter for a Chance to Win a Paul Jr. Designed Motorcycle
-
Jul 30, 2013Campaign Aims to Raise TB Awareness and Funds to Fight Lung Disease
-
Jul 25, 2013Revolutionary Tuberculosis Test Brings Accurate, Faster Results to U.S. Market